Cobas Integra Bilirubin Direct GEN.2
Diazo Colorimetry, Bilirubin. 510(k) K123965, from Roche Diagnostics (Indianapolis, IN). Product code CIG, class 2.
As of Nov 19, 2026, K123965 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Feb 28, 2013 after 64 days, with no recalls tied to it in FDA's recall database.
- Review time: 64 days
- Recalls: 0
COBAS INTEGRA Bilirubin Direct Gen.2 is an in vitro test for the quantitative determination of direct bilirubin in human serum and plasma on COBAS INTEGRA systems. Measurement of the levels of bilirubin, an organic compound formed during the normal and abnormal destruction of red blood cells, is used in the diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders…
- Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models 20737496 322, 03261638 190, and 11822713 226K063543 · Roche Diagnostics Corp. · Dec 22, 2006
- Atellica CH Diazo Total Bilirubin (D_TBil)K251998 · Siemens Healthcare Diagnostics, Inc. · Feb 27, 2026
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 26, 2012
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files